Nexome Capital Markets Limited (formerly smifs capital markets ) has announced a Rights Issue Committee meeting scheduled for February 02, 2026, marking a significant step in the company's capital raising initiative. The meeting represents a formal progression in the company's rights issue process under regulatory compliance requirements.

Meeting Details and Agenda

The Rights Issue Committee meeting will convene on Monday, February 02, 2026, at the company's registered office located at 'Vaibhav' (4F), 4, Lee Road, Kolkata - 700020. The meeting is scheduled to commence at 04:00 P.M.

Primary Objective

The committee will focus on a single critical agenda item: to consider and approve the Draft Letter of Offer in relation to the company's rights issue. This draft will subsequently be filed with BSE Limited along with their in-principle approval, representing a crucial regulatory milestone in the rights issue process.

Regulatory Compliance

The meeting notification has been issued in accordance with Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. This regulation mandates prior intimation of board and committee meetings to stock exchanges, ensuring transparency in corporate governance processes.

Corporate Communication

The official notification was digitally signed by Sanjana Gupta, Company Secretary cum Compliance Officer, on January 28, 2026. The communication was formally addressed to BSE Limited, maintaining proper regulatory protocol and ensuring all stakeholders are appropriately informed of the upcoming committee deliberations.

Nexome Capital Markets Limited (formerly smifs capital markets Limited) reported challenging financial results for the quarter ended December 31, 2025, with consolidated operations showing a significant deterioration in performance compared to the previous year.

Financial Performance Overview

The company's consolidated financial results revealed substantial losses during the third quarter of FY26. Key performance metrics demonstrate the extent of the financial challenges faced during this period.

Revenue and Operational Analysis

The company's revenue streams showed mixed performance across different business segments. Net sales and income from operations declined to ₹111.67 crores in Q3FY26 from ₹737.70 crores in Q3FY25, representing a significant 84.9% decrease. Other income remained relatively stable at ₹61.92 crores compared to ₹87.79 crores in the previous year.

Segment-wise revenue analysis revealed that Capital Market Operations generated ₹23.68 crores compared to ₹662.37 crores in Q3FY25, while Investment Banking Operations contributed ₹87.99 crores against ₹75.33 crores in the corresponding previous quarter.

Year-to-Date Performance

For the nine-month period ended December 31, 2025, the company reported consolidated net profit of ₹126.59 crores compared to ₹85.90 crores in the corresponding previous period. Total income for the year-to-date period stood at ₹2,826.34 crores compared to ₹3,317.54 crores in the previous year.

Portfolio Review and Provisions

The company conducted a comprehensive review of its loan and investment portfolio during the period. Management recognized expected credit losses on loans extended to parties and fair valuation losses on the investment portfolio based on independent valuer reports. These provisions were made in accordance with prudent accounting practices, though the company remains committed to recovery efforts for outstanding loan amounts.

Corporate Developments

Several significant corporate developments occurred during the period:

• Subsidiary Formation: The company incorporated Nexome Wealth Management Limited as a wholly owned subsidiary on July 22, 2025, to provide corporate advisory, financial consultancy services, wealth management, investment advisory, and project syndication services.

• Stock Exchange Delisting: Nexome Capital Markets received approval for voluntary delisting from The Calcutta Stock Exchange Limited on January 9, 2026, following an application filed on November 21, 2025.

• Rights Issue Committee: The Board reconstituted the Rights Issue Committee consisting of key management personnel including the Managing Director, Joint Managing Director, Independent Directors, and Company Secretary.

Capital Structure and Warrants

The company's paid-up equity share capital remained stable at ₹587.70 crores with a face value of ₹10 per share. The company had previously allotted 19,20,000 warrants to promoters and non-promoters, carrying conversion rights into equity shares at ₹10 each with a premium of ₹54 per share within 18 months from the October 25, 2024 allotment date.

The Board of Directors approved the unaudited financial results in their meeting held on January 22, 2026, with the Audit Committee reviewing the results and statutory auditors conducting a limited review of the financial statements.